Upgrade to SI Premium - Free Trial

Roth Capital Upgrades Cempra, Inc. (CEMP) to Buy Ahead Of Bone Data In 2017

February 27, 2017 9:21 AM
Roth Capital upgraded Cempra, Inc. (NASDAQ: CEMP) from Neutral to Buy with a price target of $8.00.Analyst Michael Higgins comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Upgrades Upgrades

Next Articles